FINWIRES · TerminalLIVE
FINWIRES

Update: Market Chatter: Nine Entertainment's Stan Sport Platform Sees 10% Decline in Subscribers

By

(Updates with a statement from Nine Entertainment and stock movement in the fourth paragraph.)

Nine Entertainment's (ASX:NEC) Stan Sport streaming service lost nearly 10% of its subscribers over the last 12 months, bringing into question the merits of its six-year extension to the Australian broadcast rights for the English Premier League competition, The Australian reported Sunday, citing internal Stan documents.

The number of Stan Sport subscribers declined to about 730,000 this month from a peak of 800,000 in September 2025, with Nine Entertainment's share price reaching a record low of AU$0.77 on Sept. 11, according to the report.

Anonymous senior industry executives told the new outlet that Nine effectively "bet against itself" in deciding to renew the broadcast rights since there was no official tender process and no other parties expressed interest.

In response to a query from, Nine Entertainment declined to comment on the figures reported by The Australian, but noted that a 50% increase in Stan Sport subscribers during fiscal 2026 was driven primarily by the Premier League. The company's shares rose 6% in recent Monday trade.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

What else is happening in Asia?

Asia

Orora Chief Safety, Sustainability, Governance Officer to Step Down at End of Year

Orora (ASX:ORA) said Ann Stubbings plans to step down as chief safety, sustainability, and governance officer, effective Dec. 31, after more than 13 years with the packaging products firm, according to a Monday filing with the Australian bourse.In addition, Susannah Jobling Hodgens will be appointed as chief legal officer, the company said. Hodgens has worked with Orora for 13 years in senior legal and governance roles, most recently as general counsel and alternate company secretary.Orora shares gained nearly 1% in recent Monday trade.

ASX:ORA
Asia

Biokin Pharma Enrolls First Patient in Phase Three Trial for Breast Cancer Drug; Shares Up 4%

Sichuan Biokin Pharmaceutical (SHA:688506) enrolled the first subject for the third-phase clinical trial of biologic drug T-Bren for injection, according to a weekend filing with the Shanghai bourse.The trial evaluates T-Bren combined with pertuzumab versus standard chemotherapy in neoadjuvant treatment of HER2-positive breast cancer, according to a weekend filing with the Shanghai bourse.Shares of the pharmaceutical company rose 4% in recent trade.

SHA:688506
Asia

Market Chatter: Korea Exchange to Extend Trading Hours till 8PM

South Korea's main stock market, the Korea Exchange, will enable trading till 8 pm following the regular close at 3:30 pm from Monday, in its move toward 24-hour trading, Bloomberg News reported Sunday.This decision opens 2,400 Korea Composite Stock Price Index, or Kospi, and Kosdaq stocks for evening trades, which include short-selling. The move excludes exchange-traded funds, the report said.The Korea Exchange plans to introduce pre-market trading by the end of next year, it said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

^KOSDAQKOSPI